Trial intelligence / Profile preview

Ozonated Olive Oil and Bone Substitute in Intra Bony Periodontal Defects

NCT05655923Phase 2Unknown

Sponsor
Ain Shams University
Start
Jul 2022
Primary completion
Jan 2023
Modality
Hydrogel Systems, Transdermal Patches
Countries
1
01

Overview

Phase 2, randomised trial of ozonated olive oil in periodontitis (3 arms), sponsored by Ain Shams University. Primary endpoint: Intrabony defect fill at 6 months. Status: unknown.

02

Drugs

ozonated olive oil
03

Conditions

periodontitis

Beyond the preview

Go deeper on NCT05655923.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05655923.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call